This book challenges traditional views of corporations and leadership in the knowledge economy, arguing that the current landscape has shifted. It highlights the crisis of legitimacy faced by big businesses, including trust issues in the pharmaceutical industry and growing income disparities, while critiquing the detrimental focus on shareholder value.






